Tysabri

The Top Line
Podcast

A closer look at pharma’s top patent losses in 2025

This week on "The Top Line," we explore the potential impacts of this year's sizable patent cliff on the pharma industry at large.
clock time delay cancelled month year hour

The top 10 drugs losing US exclusivity in 2025

Mar 17, 2025 3:00am
Viehbacher

Biogen places chips behind 4 new drugs as MS competition mounts

Feb 12, 2025 11:35am
Sandoz

Novartis' knockoff of Biogen's Tysabri is first MS biosim in US

Aug 25, 2023 11:28am
Biogen

Reduction of 1,000 jobs will cut Biogen's workforce by 11.5%

Jul 25, 2023 11:05am
patent litigation

Roche takes Biogen to court over royalties for Tysabri

Mar 1, 2023 5:10pm